Published in Circulation on July 01, 1976
How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. Br J Clin Pharmacol (1982) 1.51
Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin. Br J Clin Pharmacol (1979) 0.82
Right ventricular performance in essential hypertension after beta-blockade. Br Heart J (1981) 0.75
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83
Experimental annotation of the human genome using microarray technology. Nature (2001) 10.39
An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20
Polypeptides of the tail fibres of bacteriophage T4. J Mol Biol (1971) 6.97
The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med (1998) 6.75
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst (2000) 5.62
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J Clin Oncol (2001) 5.25
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A (1996) 4.45
Virus assembly. Annu Rev Biochem (1975) 3.93
Practical challenges of introducing WHO surgical checklist: UK pilot experience. BMJ (2010) 3.69
Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. J Pediatr (2000) 3.53
Assembly of the tail of bacteriophage T4. J Mol Biol (1968) 3.38
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. Clin Cancer Res (1999) 3.24
Prospective randomised controlled trial of methods of call and recall for cervical cytology screening. BMJ (1989) 3.11
Mechanism of head assembly and DNA encapsulation in Salmonella phage p22. I. Genes, proteins, structures and DNA maturation. J Mol Biol (1973) 3.10
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol (2000) 3.04
The nucleotide sequence of the Escherichia coli K12 dnaJ+ gene. A gene that encodes a heat shock protein. J Biol Chem (1986) 3.04
Pectin esterification is spatially regulated both within cell walls and between developing tissues of root apices. Planta (1990) 3.03
Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis (2000) 2.90
Laparoscopic skills training and assessment. Br J Surg (2004) 2.86
How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ (2001) 2.74
Precipitating factors leading to decompensation of heart failure. Traits among urban blacks. Arch Intern Med (1988) 2.65
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J (1991) 2.56
Disodium cromoglycate (Intal). Adv Drug Res (1970) 2.56
Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA (1999) 2.56
The DNA translocating vertex of dsDNA bacteriophage. Annu Rev Microbiol (1985) 2.55
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis (2000) 2.55
Specific aggregation of partially folded polypeptide chains: the molecular basis of inclusion body composition. Nat Biotechnol (1996) 2.52
Catalytic head assembling protein in virus morphogenesis. Nature (1974) 2.51
Popular diets: a scientific review. Obes Res (2001) 2.49
P22 morphogenesis. I: Catalytic scaffolding protein in capsid assembly. J Supramol Struct (1974) 2.44
Establishment of a Streptococcus pneumoniae nasopharyngeal colonization model in adult mice. Microb Pathog (1997) 2.41
Mechanism of head assembly and DNA encapsulation in Salmonella phage P22. II. Morphogenetic pathway. J Mol Biol (1973) 2.40
Anthropometric and biochemical changes during pregnancy in Asian and European mothers having light for gestational age babies. Br J Obstet Gynaecol (1981) 2.35
Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells. Biophys J (1993) 2.33
Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol (2001) 2.32
High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res (1999) 2.29
Comparison of dexamethasone and ondansetron in the prophylaxis of emesis induced by moderately emetogenic chemotherapy. Lancet (1991) 2.26
Two infant vision screening programmes: prediction and prevention of strabismus and amblyopia from photo- and videorefractive screening. Eye (Lond) (1996) 2.25
Long-term follow-up of porous polyethylene spherical implants after enucleation and evisceration. Ophthal Plast Reconstr Surg (2007) 2.19
Effect of passive smoking on angina pectoris. N Engl J Med (1978) 2.17
Three-dimensional transformation of capsids associated with genome packaging in a bacterial virus. J Mol Biol (1993) 2.16
Rural and urban differences in stage at diagnosis of colorectal and lung cancers. Br J Cancer (2001) 2.12
Crystal cataracts: human genetic cataract caused by protein crystallization. Proc Natl Acad Sci U S A (2001) 2.11
Carbon monoxide effect on exercise-induced angina pectoris. Ann Intern Med (1973) 2.10
Teaching and assessing ethics and law in the dental curriculum. Br Dent J (1999) 2.09
Genetic control of bacteriophage T4 baseplate morphogenesis. I. Sequential assembly of the major precursor, in vivo and in vitro. J Mol Biol (1975) 2.03
Competition among Streptococcus pneumoniae for intranasal colonization in a mouse model. Vaccine (2000) 2.00
Scaffolding protein regulates the polymerization of P22 coat subunits into icosahedral shells in vitro. J Mol Biol (1988) 1.99
The structural organization of DNA packaged within the heads of T4 wild-type, isometric and giant bacteriophages. Cell (1978) 1.99
Rural factors and survival from cancer: analysis of Scottish cancer registrations. Br J Cancer (2000) 1.97
Bacteriophage assembly. Fed Proc (1968) 1.96
Disulphide-bonded intermediate on the folding and assembly pathway of a non-disulphide bonded protein. Nat Struct Biol (1997) 1.92
Sequence analysis and transcriptional regulation of the Escherichia coli grpE gene, encoding a heat shock protein. Nucleic Acids Res (1988) 1.87
Laparoscopic virtual reality and box trainers: is one superior to the other? Surg Endosc (2004) 1.85
Qualitative and quantitative analysis of the learning curve of a simulated surgical task on the da Vinci system. Surg Endosc (2004) 1.82
The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection. Vaccine (2000) 1.82
Survival rates and prehospital delay during myocardial infarction among black persons. Am J Cardiol (1986) 1.82
Factors influencing time from presentation to treatment of colorectal and breast cancer in urban and rural areas. Br J Cancer (2004) 1.80
Structure of phage P22 coat protein aggregates formed in the absence of the scaffolding protein. J Mol Biol (1978) 1.79
Recombinational repair in yeast: functional interactions between Rad51 and Rad54 proteins. EMBO J (1997) 1.78
Local rule-based theory of virus shell assembly. Proc Natl Acad Sci U S A (1994) 1.77
Capecitabine, an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer: results of a randomized phase II study. J Clin Oncol (2000) 1.77
Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke. J Am Geriatr Soc (1998) 1.77
Genetic control of bacteriophage T4 baseplate morphogenesis. III. Formation of the central plug and overall assembly pathway. J Mol Biol (1975) 1.76
Whole proteome pI values correlate with subcellular localizations of proteins for organisms within the three domains of life. Genome Res (2001) 1.75
Global suppression of protein folding defects and inclusion body formation. Science (1991) 1.74
Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer (2005) 1.71
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. Int J Gynecol Cancer (2003) 1.70
An analysis of first-time enquirers to the CancerBACUP information service: variations with cancer site, demographic status and geographical location. Br J Cancer (1999) 1.68
A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. Br J Cancer (2006) 1.66
Clinical and economic outcomes of individuals with severe peptic ulcer hemorrhage and nonbleeding visible vessel: an analysis of two prospective clinical trials. Am J Gastroenterol (1998) 1.66
Role of the scaffolding protein in P22 procapsid size determination suggested by T = 4 and T = 7 procapsid structures. Biophys J (1998) 1.65
Bacteriophage T4 tail assembly: proteins of the sheath, core and baseplate. J Mol Biol (1973) 1.63
Medical evidence in child abuse. Arch Dis Child (1986) 1.62
Retention of urine: an unusual complication of the Plastibell device. BJU Int (1999) 1.61
Efficacy of albuterol in the management of bronchiolitis. Pediatrics (1994) 1.61
Formation of aggregates from a thermolabile in vivo folding intermediate in P22 tailspike maturation. A model for inclusion body formation. J Biol Chem (1988) 1.59
EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group. Eur J Cancer (1996) 1.58
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites. Clin Cancer Res (1999) 1.57
Impact of deprivation and rural residence on treatment of colorectal and lung cancer. Br J Cancer (2002) 1.55
The distribution of 2-acetamido-2-deoxy-D-glucose residues in mammalian heparins. Carbohydr Res (1972) 1.55
Bacteriophage T4 tail assembly: structural proteins and their genetic identification. J Mol Biol (1973) 1.55
Herbicide Resistance in Datura innoxia: Cross-Resistance of Sulfonylurea-Resistant Cell Lines to Imidazolinones. Plant Physiol (1988) 1.53
Disulfiram modulated ROS-MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer (2011) 1.53
Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma. Eur J Cancer (2001) 1.52
The benefits of stereoscopic vision in robotic-assisted performance on bench models. Surg Endosc (2004) 1.51
Steps in the stabilization of newly packaged DNA during phage P22 morphogenesis. J Mol Biol (1984) 1.51
Conformational transformations in the protein lattice of phage P22 procapsids. Biophys J (1993) 1.50
Purification and organization of the gene 1 portal protein required for phage P22 DNA packaging. Biochemistry (1988) 1.50
Effects of verapamil on myocardial performance in coronary disease. Circulation (1979) 1.50
Safety and immunogenicity of a new formulation of interferon beta-1a (Rebif New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results. Mult Scler (2008) 1.49
Trimeric intermediate in the in vivo folding and subunit assembly of the tail spike endorhamnosidase of bacteriophage P22. Proc Natl Acad Sci U S A (1982) 1.49
Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. Eur J Cancer (2002) 1.49
Genetic control of bacteriophage T4 baseplate morphogenesis. II. Mutants unable to form the central part of the baseplate. J Mol Biol (1975) 1.49
Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Ann Oncol (2003) 1.48
Sample size and statistical power in the small-animal analgesia literature. J Small Anim Pract (2007) 1.47